BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 29439902)

  • 1. MF-8, a novel promising arylpiperazine-hydantoin based 5-HT
    Latacz G; Lubelska A; Jastrzębska-Więsek M; Partyka A; Kucwaj-Brysz K; Wesołowska A; Kieć-Kononowicz K; Handzlik J
    Bioorg Med Chem Lett; 2018 Mar; 28(5):878-883. PubMed ID: 29439902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computer-aided insights into receptor-ligand interaction for novel 5-arylhydantoin derivatives as serotonin 5-HT
    Kucwaj-Brysz K; Kurczab R; Jastrzębska-Więsek M; Żesławska E; Satała G; Nitek W; Partyka A; Siwek A; Jankowska A; Wesołowska A; Kieć-Kononowicz K; Handzlik J
    Eur J Med Chem; 2018 Mar; 147():102-114. PubMed ID: 29425815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In the search for a lead structure among series of potent and selective hydantoin 5-HT
    Latacz G; Lubelska A; Jastrzębska-Więsek M; Partyka A; Sobiło A; Olejarz A; Kucwaj-Brysz K; Satała G; Bojarski AJ; Wesołowska A; Kieć-Kononowicz K; Handzlik J
    Chem Biol Drug Des; 2017 Dec; 90(6):1295-1306. PubMed ID: 28886235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational design in search for 5-phenylhydantoin selective 5-HT7R antagonists. Molecular modeling, synthesis and biological evaluation.
    Kucwaj-Brysz K; Warszycki D; Podlewska S; Witek J; Witek K; González Izquierdo A; Satała G; Loza MI; Lubelska A; Latacz G; Bojarski AJ; Castro M; Kieć-Kononowicz K; Handzlik J
    Eur J Med Chem; 2016 Apr; 112():258-269. PubMed ID: 26900658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SAR-studies on the importance of aromatic ring topologies in search for selective 5-HT(7) receptor ligands among phenylpiperazine hydantoin derivatives.
    Handzlik J; Bojarski AJ; Satała G; Kubacka M; Sadek B; Ashoor A; Siwek A; Więcek M; Kucwaj K; Filipek B; Kieć-Kononowicz K
    Eur J Med Chem; 2014 May; 78():324-39. PubMed ID: 24691057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between stereochemical and both, pharmacological and ADME-Tox, properties of the potent hydantoin 5-HT
    Kucwaj-Brysz K; Latacz G; Podlewska S; Żesławska E; Handzlik J; Lubelska A; Satała G; Nitek W; Handzlik J
    Bioorg Chem; 2021 Jan; 106():104466. PubMed ID: 33246603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aryl biphenyl-3-ylmethylpiperazines as 5-HT7 receptor antagonists.
    Kim J; Kim Y; Tae J; Yeom M; Moon B; Huang XP; Roth BL; Lee K; Rhim H; Choo IH; Chong Y; Keum G; Nam G; Choo H
    ChemMedChem; 2013 Nov; 8(11):1855-64. PubMed ID: 24039134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New dual 5-HT1A and 5-HT7 receptor ligands derived from SYA16263.
    Ofori E; Onyameh EK; Gonela UM; Voshavar C; Bricker B; Swanson TL; Eshleman AJ; Schmachtenberg JL; Bloom SH; Janowsky AJ; Ablordeppey SY
    Eur J Med Chem; 2021 Mar; 214():113243. PubMed ID: 33582388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-affinity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinealkylamides, a new class of 5-hydroxytryptamine7 receptor agents.
    Leopoldo M; Berardi F; Colabufo NA; Contino M; Lacivita E; Niso M; Perrone R; Tortorella V
    J Med Chem; 2004 Dec; 47(26):6616-24. PubMed ID: 15588097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NEW SPIROHYDANTOIN DERIVATIVES - SYNTHESIS, PHARMACOLOGICAL EVALUATION, AND MOLECULAR MODELING STUDY.
    Czopek A; Zagorska A; Kolaczkowski M; Bucki A; Gryzlo B; Rychtyk J; Pawlowsk M; Siwek A; Satala G; Bojarski A; Kubacka M; Filipek B
    Acta Pol Pharm; 2016 Nov; 73(6):1545-1554. PubMed ID: 29634109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel spirohydantoin derivative as a potent multireceptor-active antipsychotic and antidepressant agent.
    Czopek A; Kołaczkowski M; Bucki A; Byrtus H; Pawłowski M; Kazek G; Bojarski AJ; Piaskowska A; Kalinowska-Tłuścik J; Partyka A; Wesołowska A
    Bioorg Med Chem; 2015 Jul; 23(13):3436-47. PubMed ID: 25936259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and structure-activity relationships of new carbonyl guanidine derivatives as novel dual 5-HT2B and 5-HT7 receptor antagonists.
    Moritomo A; Yamada H; Watanabe T; Itahana H; Akuzawa S; Okada M; Ohta M
    Bioorg Med Chem; 2013 Dec; 21(24):7841-52. PubMed ID: 24189186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of 1-[2-(4-[(11)C]methoxyphenyl)phenyl]piperazine for imaging of the serotonin 5-HT7 receptor in the rat brain.
    Shimoda Y; Yui J; Xie L; Fujinaga M; Yamasaki T; Ogawa M; Nengaki N; Kumata K; Hatori A; Kawamura K; Zhang MR
    Bioorg Med Chem; 2013 Sep; 21(17):5316-22. PubMed ID: 23830697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aminoalkyl Derivatives of 8-Alkoxypurine-2,6-diones: Multifunctional 5-HT
    Chłoń-Rzepa G; Zagórska A; Żmudzki P; Bucki A; Kołaczkowski M; Partyka A; Wesołowska A; Kazek G; Głuch-Lutwin M; Siwek A; Starowicz G; Pawłowski M
    Arch Pharm (Weinheim); 2016 Dec; 349(12):889-903. PubMed ID: 27869315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of the halogen bonding on D
    Partyka A; Kurczab R; Canale V; Satała G; Marciniec K; Pasierb A; Jastrzębska-Więsek M; Pawłowski M; Wesołowska A; Bojarski AJ; Zajdel P
    Bioorg Med Chem; 2017 Jul; 25(14):3638-3648. PubMed ID: 28529043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single Administration of HBK-15-a Triple 5-HT
    Pytka K; Głuch-Lutwin M; Kotańska M; Waszkielewicz A; Kij A; Walczak M
    Mol Neurobiol; 2018 May; 55(5):3931-3945. PubMed ID: 28550529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards new 5-HT7 antagonists among arylsulfonamide derivatives of (aryloxy)ethyl-alkyl amines: Multiobjective based design, synthesis, and antidepressant and anxiolytic properties.
    Canale V; Kurczab R; Partyka A; Satała G; Lenda T; Jastrzębska-Więsek M; Wesołowska A; Bojarski AJ; Zajdel P
    Eur J Med Chem; 2016 Jan; 108():334-346. PubMed ID: 26698537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel anilide and benzylamide derivatives of arylpiperazinylalkanoic acids as 5-HT
    Jankowska A; Satała G; Kołaczkowski M; Bucki A; Głuch-Lutwin M; Świerczek A; Pociecha K; Partyka A; Jastrzębska-Więsek M; Lubelska A; Latacz G; Gawalska A; Bojarski AJ; Wyska E; Chłoń-Rzepa G
    Eur J Med Chem; 2020 Sep; 201():112437. PubMed ID: 32673902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New arylpiperazine 5-HT(1A) receptor ligands containing the pyrimido[2,1-f]purine fragment: synthesis, in vitro, and in vivo pharmacological evaluation.
    Jurczyk S; Kołaczkowski M; Maryniak E; Zajdel P; Pawłowski M; Tatarczyńska E; Kłodzińska A; Chojnacka-Wójcik E; Bojarski AJ; Charakchieva-Minol S; Duszyńska B; Nowak G; Maciag D
    J Med Chem; 2004 May; 47(10):2659-66. PubMed ID: 15115407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel highly potent serotonin 5-HT7 receptor ligands: structural modifications to improve pharmacokinetic properties.
    Lacivita E; Di Pilato P; Stama ML; Colabufo NA; Berardi F; Perrone R; De Filippis B; Laviola G; Adriani W; Niso M; Leopoldo M
    Bioorg Med Chem Lett; 2013 Nov; 23(22):6083-6. PubMed ID: 24100077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.